CytomX

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.

CEO

Sean A. McCarthy

CEOSean A. McCarthy

Employees

121

Employees121

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2010

Founded2010

Employees

121

Employees121

CTMX Key Statistics

Market cap

56.89M

Market cap56.89M

Price-Earnings ratio

2.04

Price-Earnings ratio2.04

Dividend yield

—

Dividend yield—

Average volume

968.12K

Average volume968.12K

High today

$0.7696

High today$0.7696

Low today

$0.7011

Low today$0.7011

Open price

$0.7695

Open price$0.7695

Volume

718.22K

Volume718.22K

52 Week high

$5.85

52 Week high$5.85

52 Week low

$0.40

52 Week low$0.40

CytomX

Why Robinhood?

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Show more

CTMX Key Statistics

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.